SEARCH RESULTS FOR: （薇信11008748）推特微密圈Onlyfans推荐大啵G奶御姐喵了个眯儿道具自慰炮机爆操爽晕了.dxl(4169 results)
BMET-11A, F/G
PN 74075-01M
RANFAC CORP.
11 GAUGE x 4"
In Commercial Distribution
- M9797407501M9 ()
- M9797407501M0 ()
- Length: 4 Inch
- Needle Gauge: 11 Gauge
BMET-11A
- Bone marrow biopsy procedure kit
No Description
G21 SRL
611-01-140
In Commercial Distribution
- 08058964729026 ()
- Orthopaedic cement, antimicrobial
No Description
G21 SRL
610-01-140
In Commercial Distribution
- 08058964729019 ()
- Orthopaedic cement, antimicrobial
Contains VT601US(ES,VS×2), 4 of cryotopUSs(Green)and Repro Plate
KITAZATO CORPORATION
VT601US-TOP(G)
In Commercial Distribution
- 24582231462616 ()
- 14582231462596 ()
- IVF medium kit
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-06
In Commercial Distribution
- 07350055430530 ()
- Total Volume: 5 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-05
In Commercial Distribution
- 07350055430523 ()
- Total Volume: 10 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system or inserted as pre-set beads.
Bone Support AB
A0450-11
In Commercial Distribution
- 07350055430394 ()
- Total Volume: 5 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system or inserted as pre-set beads.
Bone Support AB
A0450-10
In Commercial Distribution
- 07350055430387 ()
- Total Volume: 10 Milliliter
- Bone matrix implant, synthetic, antimicrobial
MYELOGRAM PK,STRL F G
Cardinal Health 200, LLC
SMY21MYSJG
In Commercial Distribution
- 50888439643396 ()
- 10888439643398 ()
SMY21MYSJG
- General surgical procedure kit, non-medicated, single-use
212515 G U RADICAL PACK
Cardinal Health 200, LLC
SOT2DGUCFA
In Commercial Distribution
- 50888439681862 ()
- 10888439681864 ()
SOT2DGUCFA
- Urological surgical procedure kit, non-medicated, single-use